The gene therapy drug for the rare spinal muscular atrophy (SMA) will be covered by the taiwan national health insurance starting in August. The asking price for one dose is NT$49 million. It is estimated that 8 sick children will benefit in a year. 6 months baby who is born in taiwan,tainan will got it.